Cargando…
Wilms’ tumour gene 1 (WT1) enhances non-small cell lung cancer malignancy and is inhibited by microRNA-498-5p
BACKGROUND: Wilms’ tumour gene 1 (WT1) is clearly recognized as a tumour promoter in diversiform of human malignancies. Nevertheless, knowledge of its expression, functions and potential molecular mechanisms in non-small cell lung cancer (NSCLC) remains elusive. METHODS: Differential expression of W...
Autores principales: | Li, Xuebing, An, Wenzhe, Pan, Hongli, Fan, Yaguang, Huang, Hua, Wang, Yixuan, Shen, Wang, Zu, Lingling, Meng, Fanrong, Zhou, Xuexia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476375/ https://www.ncbi.nlm.nih.gov/pubmed/37667197 http://dx.doi.org/10.1186/s12885-023-11295-2 |
Ejemplares similares
-
Correction: Wilms’ tumour gene 1 (WT1) enhances non-small cell lung cancer malignancy and is inhibited by microRNA-498-5p
por: Li, Xuebing, et al.
Publicado: (2023) -
Wilms’ Tumour gene 1 (WT1) as an immunotherapeutic target
por: Coosemans, A.
Publicado: (2011) -
Diagnostic utility of Wilms’ tumour-1 protein (WT-1) immunostaining in paediatric renal tumours
por: Goyal, Surbhi, et al.
Publicado: (2016) -
Activating transcription factor 3 promotes malignance of lung cancer cells in vitro
por: Li, Xuebing, et al.
Publicado: (2017) -
A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation
por: Kaneko, Y, et al.
Publicado: (2015)